Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - lansoprazole - gastro-resistant capsule, hard - 15 milligram(s) - proton pump inhibitors; lansoprazole

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - lansoprazole - gastro-resistant capsule, hard - 30 milligram(s) - proton pump inhibitors; lansoprazole

Indja - Ingliż - Central Drugs Standard Control Organization

cipla - lansoprazole - dt - 30mg - 10

Indja - Ingliż - Central Drugs Standard Control Organization

cipla - lansoprazole - 15mg - 5.6 gm sachet

Ġordan - Ingliż - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة الأردنية السويدية - jordan sweden medical & sterilization co. - lansoprazole 15 mg - 15 mg

Ġordan - Ingliż - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة الأردنية السويدية - jordan sweden medical & sterilization co. - lansoprazole 30 mg - 30 mg

Ġordan - Ingliż - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة الأردنية السويدية - jordan sweden medical & sterilization co. - lansoprazole 15 mg - 15 mg

Ġordan - Ingliż - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة الأردنية السويدية - jordan sweden medical & sterilization co. - lansoprazole 30 mg - 30 mg

Namibja - Ingliż - Namibia Medicines Regulatory Council

ranbaxy (sa) (pty) ltd - lansoprazole - capsules - each capsule contains lansoprazole 30.0 mg

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - lansoprazole, quantity: 30 mg - capsule - excipient ingredients: methacrylic acid - ethyl acrylate copolymer (1:1); hypromellose; indigo carmine; colloidal anhydrous silica; titanium dioxide; maize starch; purified talc; macrogol 300; sucrose; carmoisine; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; strong ammonia solution; ethanol absolute; iron oxide black; ethanol; shellac; sulfuric acid - adults:. lanzopran capsules are indicated for. - healing and long-term management of reflux oesophagitis. . - healing and long-term management for patients with duodenal ulcer.. - healing of benign gastric ulcer. patients whose gastric or duodenal ulcer is not associated with ingestion of non-steroidal anti-inflammatory drugs require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. . - patients with benign peptic lesions that do not respond to h2-receptor antagonists.. - eradication of h. pylori from the upper gastrointestinal tract in patients with peptic ulcer or chronic gastritis when used in combination with appropriate antibiotics. . - relief of reflux-like and/or ulcer-like symptoms associated with acid-related dyspepsia. . paediatric and adolescent patients i to 17 years of age:. lanzopran capsules are indicated for. - treatment of gastro-oesophageal reflux disease, including all grades of oesophagitis. . - healing of erosive oesophagitis.